Medical Devices News

Monday, February 13, 2012

Oxford Immunotec taps Altieri as CFO
After serving two years as the chief financial officer of New Hampshire-based Salient Surgical Technologies, Richard Altieri will now take the financial reigns of another medical technology business, this time for a company in Massachusetts.

Friday, February 10, 2012

Post-buyout, Atrium Medical plans new site
Atrium Medical Corp., the Hudson, N.H.-based medical devices firm acquired by Swedish company Getinge Group in October, will not be building a new facility in Merrimack, N.H. Instead, the company will look to occupy an existing facility in Merrimack, according to a published report.

Thursday, February 9, 2012

Hologic, Conceptus both file appeals in patent case
The legal fight between Hologic Inc. of Bedford and California firm Conceptus Inc. continues with Conceptus appealing a court’s ruling that denied its motion to stop Hologic from selling its Adiana permanent contraception system. In addition, Hologic filed an appeal of a jury verdict that found it had infringed on a Conceptus patent.

Wednesday, February 8, 2012

Harvard Bioscience buys German lab product maker
Harvard Bioscience Inc., a maker of scientific instruments and apparatuses, continues its small buying spree with its latest acquisition of AHN Biotechnologie GmbH of Germany, announced today in a news release.
NeuroMetrix eyes $10.5M from securities offering
NeuroMetrix Inc., a Waltham medical device firm, is seeking $10.5 million from a public offering of stock and warrants. The company said it expects to apply the proceeds to commercializing its nerve conduction test and developing its pain therapy device.

Tuesday, February 7, 2012

Ocular Therapeutix advances eye sealant to trial
Bedford-based Ocular Therapeutix Inc. has won investigational device exemption (IDE) approval from the U.S. Food and Drug Administration, clearing the way for its ReSure Sealant to be tested in clinical trials.

Monday, February 6, 2012

UV Flu's note sale almost kills all debt
Cape Cod's UV Flu Technologies Inc. said in a release that it is paying off its last convertible note ahead of schedule, in an effort to eliminate all company debt.
Brown University biochip may lead to saliva glucose detector
Brown University researchers have created an experimental biochip that may one day test for miniscule levels of glucose in saliva rather than requiring diabetics to suffer repeated and painful finger pricks, lead scientist Domenico Pacifici told Mass High Tech in an interview.
MindChild Medical seeks FDA nod for fetal heart monitor
North Andover startup MindChild Medical Inc. has filed a 510(k) pre-market notification application with the U.S. Food and Drug Administration for its Meridian non-invasive fetal heart monitor.

Friday, February 3, 2012

Rep. Markey bill would block medical devices linked to recalls
Rep. Edward Markey and several colleagues earlier this week introduced legislation they claim closes a major loophole in the 510(k) medical device approval process by blocking U.S. Food and Drug Administration approval of a medical device if it is based on an earlier product that was pulled from the market for causing patients serious harm.

Thursday, February 2, 2012

Boston Scientific's new stent gets first patient implant
Boston Scientific Corp. has brought its newly approved drug-eluting stent, the Promus Element Plus Everolimus-Eluting Platinum Chromium Coronary Stent System, to Europe with its first patient implant.

Tuesday, January 31, 2012

Navilyst Medical to be bought for $372M by AngioDynamics
Navilyst Medical of Marlborough, a privately held maker of medical devices for vascular access, will be acquired for $372 million by AngioDynamics, another medical device maker based in Albany, N.Y.

Monday, January 30, 2012

Covidien device joins stroke treatment trial
The Solitaire FR Revascularization Device by Covidien plc won approval for investigational use in the thromectomy part of the Interventional Management of Stroke trial, funded by the National Institute of Neurological Disorders and Stroke.
FDA OKs Cynosure cellulite reduction device
Cynosure Inc., a healthcare and aesthetics systems maker in Westford, scored an approval by the U.S. Food and Drug Administration to commercialize Cellulaze, its minimally invasive device to reduce cellulite.
ConforMIS grabs $89 Million in Series E financing
In what it is claiming is one of the largest fundraisings by a private healthcare company in 2011, medical device company ConforMIS Inc. of Burlington has pulled in $89 million in a Series E round of funding, with additional funds beyond the amount committed upon meeting certain milestones.

Thursday, January 26, 2012

Stretchable electronics firm MC10 boosted by $2M funding
Cambridge startup MC10 Inc., a maker of flexible electronics, raised $2 million in a funding round from Aberdare Ventures of San Francisco. As part of the investment, Aberdare managing partner Paul Klingenstein will join the MC10 board of directors.

Wednesday, January 25, 2012

Mevion Medical finds $45M in VC funding
Littleton’s Mevion Medical Systems said Wednesday it closed a $45 million investment to help the company commercialize its proton beam radiation therapy systems.
Insulin spray maker Generex pulls in $3.55M in loans
Generex Biotechnology Corp., of both Worcester and Toronto, is getting a boost of about $3.55 million U.S. dollars (CA $3.6M) through two loans expected to support its redevelopment plans, the company said in a news release today.

Monday, January 23, 2012

Boston Scientific cleared of 2008 J&J patent suit
Boston Scientific Corp. has won a patent infringement lawsuit that Johnson & Johnson Co. brought against the Natick medical device company in 2008.
Alere's rapid flu test gets FDA waiver
Alere Inc., a Waltham healthcare management company, said today that it received clearance from the U.S. Food and Drug Administration for its influenza A&B test for the U.S. market.